Current rules only require approval from manufacturers; the proposal extends this to sellers and distributors.
The aim is to reduce unauthorized promotion and unsafe self‑medication.
The amendment follows recommendations from the Drugs Technical Advisory Board.
Feedback from the public will be considered before finalising the rule.
The draft amendment would require prior government approval for ads by retailers, wholesalers and distributors.
The change targets medicines that need medical supervision, such as certain antibiotics and psychotropic drugs.
The public is invited to submit comments on the proposal within 30 days.
Want to learn even more? Click here to read the full story!